Papers to Appear in Forthcoming Issues

Repression of Interleukin-2 mRNA Translation in Primary Human Breast Carcinoma Tumor-Infiltrating Lymphocytes. Carolina B. Lopez, T. Dharma Rao, Helen Feiner, Richard Shapiro, Jeffrey R. Marks, and Alan B. Frey. (Received 6/3/98; accepted 9/1/98.) Epithelial Cells Modulating HLA Class I Surface Molecules Are Susceptible to Lysis Mediated by CD3+and CD3−“Nonspecific” Killer Cells. Claudia Semino, Gabriella Pietra, Antonio Semino, Michela Falco, Marco Varaldo, and Giovanni Melioli. (Received 2/22/98; accepted 9/1/98.) tion of Experimental Allergic Encephalomyelitis by an Antibody to CD45RB. J. Schiffenbauer, E. Butfiloski. G. Hanley, E. S. Sobel, W. J. Streit, and A. Lazarovits. (Received 6/16/98; accepted 9/2/98.) sed Zap-70 Association with CD3ζ in CD4 T Cells from Old Mice. Gonzalo G. Garcia and Richard A. Miller. (Received 6/30/98; accepted 9/2/98.) Cells Express 4-1BB (CDw137) Costimulatory Molecule and Are Required for Tumor Immunity Elicited by Anti-4-1BB Monoclonal Antibodies. Ignacio Melero, Janet V. Johnston, Walter W. Shufford, Robert S. Mittler, and Lieping Chen. (Received 2/10/98; accepted 9/9/98.) fication of Two Regions in the Cytoplasmic Domain of CD44 through Which PMA, Calcium, and Foskolin Differentially Regulate the Binding of CD44 to Hyaluronic Acid. Dacai Liu, Tong Liu, and Man-Sun Sy. (Received 7/8/98; accepted 9/9/98.)